Blackstone Group »

Terns Pharmaceuticals shares owned by Blackstone Group

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Blackstone Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $19M 477k 40.40